Consistent with this hypothesis, we recently demonstrated that downregulation of KATP function in smooth muscle, using transgenic, tissue-specific, dominant-negative Kir6.1 subunits, reverses cardiac hypertrophy in ABCC9-mutant (SUR2wt/AV) mice.20 The gene discussed is ABCC9; the disease is cardiac hypertrophy.